ArticleJournal of affective disorders2026
Multi-marker cerebral small vessel disease score and risk of incident depression: The Framingham Heart Study.
Article in Journal of affective disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Depression and anxiety in vascular dementia: an update.Journal of neural transmission (Vienna, Austria : 1996) · 2026Review
- Associations of Brain Structure and Neuropsychological Function With Artificial Intelligence Estimates of Biological Vascular Age.Arteriosclerosis, thrombosis, and vascular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe vascular depression hypothesis postulates that cerebral small vessel disease (CSVD) contributes to the development of depression. This study examined the relationship between a multi-marker CSVD score derived from brain magnetic resonance imaging (MRI) with incident depression in community-dwelling individuals.
methodsFramingham Heart Study (FHS) participants free of stroke, dementia, and depression with available data on CSVD MRI markers were included. The CSVD score was calculated by summing one point for each individual CSVD marker: covert brain infarcts, cerebral microbleeds, white matter hyperintensities, visible perivascular spaces (PVS) and cortical superficial siderosis, ranging 0-5. Depression was defined as Center for Epidemiological Studies Depression scale score ≥ 16 or antidepressant used. Multivariable logistic regression models were used to relate the CSVD score and individual markers to incident depression. Models were adjusted for age, sex, FHS cohort, time interval between MRI and clinic exam, and regular vascular risk factors.
resultsAmong 1768 participants, (mean age 54.4 ± 12.4 years, 54 % male), 11 % developed depression (median follow-up 6.0 years, IQR: 5.25-6.70). No CSVD score group, or individual marker had a statistically significant association with incident depression. However, both a CSVD score of 3+ (OR: 2.72, 95 %, CI 0.90, 8.19, p = 0.09) and the presence of visible PVS (OR: 1.56, CI 0.97, 2.52, p = 0.07) showed a trend towards increased odds of developing depression.
conclusionA high CSVD burden and the presence of visible PVS may be related to incident depression. Validation in larger and more diverse cohorts is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.